Allurion Technologies (ALURD) Shares Outstanding (2022 - 2026)
Allurion Technologies' (ALURD) quarterly Shares Outstanding (Entity) came in at $15.0 million in Q1 2026, up 213.79% YoY from $4.8 million in Q1 2025, and up 98.75% on a QoQ basis from $7.5 million in Q4 2025.
Allurion Technologies (ALURD) Shares Outstanding (2022 - 2026) Analysis & Trends
Allurion Technologies (ALURD) has 5 years of Shares Outstanding (Entity) data on file, last reported at $15.0 million in Q1 2026.
- Quarterly Shares Outstanding (Entity) rose 213.79% year-over-year to $15.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.0 million (up 213.79% YoY) and the FY2025 annual result came in at $7.5 million, up 235.74% from the prior year.
- Shares Outstanding (Entity) improved to $15.0 million in Q1 2026, from $7.5 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $15.0 million in Q1 2026 to a low of $298704.0 in Q2 2022.
- A 5-year average of $4.0 million and a median of $1.9 million in 2024 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) climbed 2.84% — and 2024, when it soared 524.7%.
- Tracing ALURD's Shares Outstanding (Entity) over 5 years: stood at $1.1 million in 2022, then soared by 32.18% to $1.4 million in 2023, then soared by 57.89% to $2.2 million in 2024, then surged by 235.74% to $7.5 million in 2025, then surged by 98.75% to $15.0 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $15.0 million (Q1 2026), $7.5 million (Q4 2025), and $13.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 383.50 Mn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 576.40 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 382.20 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 453.00 Mn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 955.57 Mn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Allurion Technologies | 49.18 Mn | 44.13 Mn | 1.23 Mn | 13.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.35 Mn |
| Dec 31, 2025 | 7.54 Mn |
| Sep 30, 2025 | 13.77 Mn |
| Jun 30, 2025 | 7.30 Mn |
| Mar 31, 2025 | 4.78 Mn |
| Dec 31, 2024 | 2.25 Mn |
| Sep 30, 2024 | 2.56 Mn |
| Jun 30, 2024 | 1.92 Mn |
| Mar 31, 2024 | 1.91 Mn |
| Dec 31, 2023 | 1.42 Mn |
| Sep 30, 2023 | 1.61 Mn |
| Jun 30, 2023 | 307,174.00 |
| Mar 31, 2023 | 1.08 Mn |
| Dec 31, 2022 | 1.08 Mn |
| Sep 30, 2022 | 1.08 Mn |
| Jun 30, 2022 | 298,704.00 |